PARK2andPACRGare commonly downregulated in clear-cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcome
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2014 ◽
Vol 45
(2)
◽
pp. 202-209
◽
Keyword(s):
2013 ◽
Vol 42
(6)
◽
pp. 2078-2086
◽
Keyword(s):
2016 ◽
Keyword(s):
2015 ◽
Vol 37
(8)
◽
pp. e75-e76
◽
Keyword(s):
2014 ◽
Vol 42
(2)
◽
pp. 282-291
◽
Keyword(s):